
Anisic acid | CAS:100-09-4
Anisic acid
- 名称:对甲氧基苯甲酸; 4-甲氧基苯甲酸 | Anisic acid
- CAS号:100-09-4
- 别名:4-Methoxybenzoic acid; p-Anisic acid; p-Methoxybenzoic acid
- 分子式:C8H8O3
- 分子量:152.15
- EINESC号:202-818-5
产品描述
物理化学性质
熔点 | 181-186 ºC |
---|---|
沸点 | 275 ºC |
闪点 | 185 ºC |
密度 | 1.385 |
折射率 | 1.571-1.576 |
安全数据
安全说明书 | S24/25 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
文章
同行评议文献
Thermodynamic investigations of nitroxoline sublimation by simultaneous DSC-FTIR method and isothermal TG analysis.Gau-Yi Gao et al.Journal of pharmaceutical sciences, 99(1), 255-261 (2009-06-17)
Effect of nitroxoline on angiogenesis and growth of human bladder cancer.Joong Sup Shim et al.Journal of the National Cancer Institute, 102(24), 1855-1873 (2010-11-20)
The urinary antibiotic 5-nitro-8-hydroxyquinoline (Nitroxoline) reduces the formation and induces the dispersal of Pseudomonas aeruginosa biofilms by chelation of iron and zinc.A Sobke et al.Antimicrobial agents and chemotherapy, 56(11), 6021-6025 (2012-08-29)
[Microbiological consequences of chelation of bivalent metal cations by nitroxoline].C Pelletier et al.Pathologie-biologie, 42(5), 406-411 (1994-05-01)
Substituted oxines inhibit endothelial cell proliferation and angiogenesis.Shridhar Bhat et al.Organic & biomolecular chemistry, 10(15), 2979-2992 (2012-03-07)
Development of new cathepsin B inhibitors: combining bioisosteric replacements and structure-based design to explore the structure-activity relationships of nitroxoline derivatives.Izidor Sosič et al.Journal of medicinal chemistry, 56(2), 521-533 (2012-12-21)
Effects of subinhibitory concentrations of nitroxoline on the surface properties of Escherichia coli.H Latrache et al.Folia microbiologica, 45(6), 485-490 (2001-08-15)
[Present status of nitroxoline].E Bergogne-Berezin et al.Pathologie-biologie, 35(5 Pt 2), 873-878 (1987-06-01)
Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline).Hongchao Jiang et al.Cancer letters, 312(1), 11-17 (2011-09-09)
[Intensive combined therapy of patients with urogenital tuberculosis].B V Soloveĭ et al.Problemy tuberkuleza, (1)(1), 30-32 (1995-01-01)
[Relation of the chelating property of nitroxoline, the surface hydrophobicity and the inhibition of bacterial adherence].P Bourlioux et al.Pathologie-biologie, 37(5 Pt 2), 600-604 (1989-06-01)
Roles of divalent cations and pH in mechanism of action of nitroxoline against Escherichia coli strains.C Pelletier et al.Antimicrobial agents and chemotherapy, 39(3), 707-713 (1995-03-01)
Powder diffraction study of the hydrogen bonds in nitroxoline and its hydrochloride.A V Yatsenko et al.Acta crystallographica. Section C, Crystal structure communications, 58(Pt 1), o19-o21 (2002-01-10)
[The characteristics of extracting 2-acetylamino-5-nitrothiazole and 5-nitro-8-hydroxyquinoline from aqueous solutions].V K Shormanov et al.Sudebno-meditsinskaia ekspertiza, 37(3), 26-28 (1994-07-01)
Electrochemistry of the antibacterial and antifungal drug nitroxoline and its determination in bulk form, pharmaceutical formulation and human blood.Mohamed M Ghoneim et al.Bioelectrochemistry (Amsterdam, Netherlands), 80(2), 162-168 (2010-09-14)
Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells.Serena Veschi et al.Journal of experimental & clinical cancer research : CR, 37(1), 236-236 (2018-09-23)
[Urinary tract infections in Dakar: etiologies, therapeutic basis].A I Sow et al.Dakar medical, 45(1), 59-61 (2003-12-12)
[Inhibition of bacterial adherence by nitroxoline on cellular adhesion and on urinary catheter surfaces].P Bourlioux et al.Pathologie-biologie, 37(5), 451-454 (1989-05-01)
[Direct effect of nitroxoline in the inhibition of bacterial adherence to urinary catheters].L Oliviero et al.Pathologie-biologie, 38(5), 455-458 (1990-05-01)
Activity in vitro of urine samples from patients treated by nitroxoline against mycoplasmas.A Amgar et al.Journal of chemotherapy (Florence, Italy), 1(4 Suppl), 226-228 (1989-07-01)
In vitro activity of the chelating agents nitroxoline and oxine against Mycobacterium bovis BCG.B Murugasu-Oei et al.International journal of antimicrobial agents, 18(6), 579-582 (2001-12-12)
Synthesis and evaluation of a large library of nitroxoline derivatives as pancreatic cancer antiproliferative agents.Serena Veschi et al.Journal of enzyme inhibition and medicinal chemistry, 35(1), 1331-1344 (2020-06-27)
Redox-based inactivation of cysteine cathepsins by compounds containing the 4-aminophenol moiety.Bojana Mirković et al.PloS one, 6(11), e27197-e27197 (2011-11-11)
[Disorders of kidney function in patients with benign prostatic hyperplasia].V E Rodoman et al.Urologiia i nefrologiia, (6)(6), 24-26 (1998-02-14)
In vitro activity of nitroxoline against clinical isolates of Candida species.J M Hernández Molina et al.Mycoses, 34(7-8), 323-325 (1991-07-01)
[Antifungal activity of nitroxoline].J M Hernández et al.Enfermedades infecciosas y microbiologia clinica, 9(7), 439-440 (1991-08-01)
Experimental and theoretical quantum chemical investigations of 8-hydroxy-5-nitroquinoline.V Arjunan et al.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 96, 506-516 (2012-06-26)
Nitroxoline: a potent antimicrobial agent against multidrug resistant Enterobacteriaceae.Rungrot Cherdtrakulkiat et al.EXCLI journal, 18, 445-453 (2019-08-20)
[Is nitroxoline an allergen?].F Rodor et al.Therapie, 57(2), 204-205 (2002-08-21)
Highly CO2-soluble 5-Amido-8-hydroxyquinoline Chelating Agents for Extraction of Metals in Sc-CO2.Chang F, et al. Bull. Korean Chem. Soc., 29(7), 1327-1327 (2008)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
RelatedAPI's
名称 | CAS号 | |
---|---|---|
Amiodarone | 1951-25-3 | 查看 |

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!